EP2046815 - ANTI-INFLAMMATORY AND ANTIALLERGIC CYCLIC PEPTIDES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.06.2013 Database last updated on 26.04.2025 | Most recent event Tooltip | 17.07.2015 | Lapse of the patent in a contracting state New state(s): HU | published on 19.08.2015 [2015/34] | Applicant(s) | For all designated states CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA. Rodovia Itapira/Iindoia, Km 14 13970-000 Itapira / BR | For all designated states Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP Rua Pio XI, 1500 - Alto da Lapa 05468-901 São Paulo / BR | For all designated states Ferreira, Mônica Av. Vital Brasil 1500 Laboratório Especial De Toxicologia Aplicada Instituto Butantan Centro DeToxicologiaAplicada/cepid 05503-900 São Paulo / BR | [2009/16] | Inventor(s) | 01 /
FERREIRA, Mônica Av. Vital Brasil 1500 Laboratório Especial De Toxicologia Aplicada Instituto Butantan Centro DeToxicologiaAplicada/cepid 05503-900 São Paulo / BR | 02 /
SILVA, Carla Av. Vital Brasil, 1500 Laboratório Especial De Toxicologia Aplicada Instituto Butantan Centro DeToxicologia Aplicada/cepid 05503-900 São Paulo / BR | 03 /
PIMENTA, Daniel Av. Vital Brasil, 1500 Laboratório De Bioquímica E Biofísica Instituto Butantan 05503-900 São Paulo / BR | 04 /
PORTARO, Fernanda Av. Vital Brasil, 1500 Laboratório De Imunoquímica Instituto Butantan 05503-900 São Paulo / BR | 05 /
CONCEIÇÃO, Kátia Av. Vital Brasil, 1500 Laboratório Especial De Toxicologia Aplicada Instituto Butantan, Centro DeToxicologia Aplicada/cepid 05503-900 São Paulo / BR | 06 /
DEMASI, Marilene Av. Vital Brasil, 1500 Laboratório De Bioquímica E Biofísica Instituto Butantan 05503-900 São Paulo / BR | [2012/32] |
Former [2009/16] | 01 /
FERREIRA, Mônica Av. Vital Brasil 1500 Laboratório Especial De Toxicologia Aplicada Instituto Butantan Centro DeToxicologiaAplicada/cepid 05503-900 São Paulo / BR | ||
02 /
SILVA, Carla Av. Vital Brasil, 1500 Laboratório Especial De Toxicologia Aplicada Instituto Butantan Centro DeToxicologia Aplicada/cepid 05503-900 São Paulo / BR | |||
03 /
PIMENTA, Daniel Av. Vital Brasil, 1500 Laboratório De Bioquímica E Biofísica Instituto Butantan 05503-900 São Paulo / BR | |||
04 /
PORTARO, Fernanda Av. Vital Brasil, 1500 Laboratório De Imunoquímica Instituto Butantan 05503-900 São Paulo / BR | |||
05 /
CONCEIÇÃO, Kátia Av. Vital Brasil, 1500 Laboratório Especial De Toxicologia Aplicada Instituto Butantan Centro DeToxicologia Aplicada/cepid 05503-900 São Paulo / BR | |||
06 /
DEMASI, Marilene Av. Vital Brasil, 1500 Laboratório De Bioquímica E Biofísica Instituto Butantan 05503-900 São Paulo / BR | Representative(s) | Alves Moreira, Pedro Raul César Ferreira (Herd.), Lda. Rua do Patrocinio, 94 1399-019 Lisbon / PT | [N/P] |
Former [2012/32] | Alves Moreira, Pedro Raul César Ferreira (Herd.), Lda. Rua do Patrocinio, 94 1399-019 Lisbon / PT | ||
Former [2009/16] | Alves Moreira, Pedro Raul César Ferreira (Herd.), Lda. Rua do Patrocinio, 94 1399-019 Lisbon / PT | Application number, filing date | 07784915.6 | 19.07.2007 | [2009/16] | WO2007BR00186 | Priority number, date | BR2006PI02885 | 21.07.2006 Original published format: BR PI0602885 | BR2007PI03175 | 04.07.2007 Original published format: BR PI0703175 | [2010/11] |
Former [2009/16] | BR2006PI02885 | 21.07.2006 | |
BR2007PI90499 | 04.07.2007 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008009085 | Date: | 24.01.2008 | Language: | EN | [2008/04] | Type: | A1 Application with search report | No.: | EP2046815 | Date: | 15.04.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.01.2008 takes the place of the publication of the European patent application. | [2009/16] | Type: | B1 Patent specification | No.: | EP2046815 | Date: | 08.08.2012 | Language: | EN | [2012/32] | Search report(s) | International search report - published on: | AT | 24.01.2008 | (Supplementary) European search report - dispatched on: | EP | 25.08.2010 | Classification | IPC: | C07K7/64, C07K7/08, C07K14/46, C07K14/81 | [2010/38] | CPC: |
C07K14/461 (EP);
C07K14/811 (EP);
C07K7/08 (EP);
A61K38/00 (EP)
|
Former IPC [2009/16] | C07K7/64 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/16] | Title | German: | ENTZÜNDUNGSHEMMENDE UND ANTIALLERGISCHE CYCLISCHE PEPTIDE | [2009/16] | English: | ANTI-INFLAMMATORY AND ANTIALLERGIC CYCLIC PEPTIDES | [2009/16] | French: | PEPTIDES CYCLIQUES ANTI-INFLAMMATOIRES ET ANTIALLERGIQUES | [2009/16] | Entry into regional phase | 28.01.2009 | National basic fee paid | 28.01.2009 | Search fee paid | 28.01.2009 | Designation fee(s) paid | 28.01.2009 | Examination fee paid | Examination procedure | 28.01.2009 | Examination requested [2009/16] | 11.03.2011 | Amendment by applicant (claims and/or description) | 15.09.2011 | Despatch of a communication from the examining division (Time limit: M04) | 13.01.2012 | Reply to a communication from the examining division | 19.03.2012 | Communication of intention to grant the patent | 28.06.2012 | Fee for grant paid | 28.06.2012 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.09.2011 | Opposition(s) | 10.05.2013 | No opposition filed within time limit [2013/29] | Fees paid | Renewal fee | 28.01.2009 | Renewal fee patent year 03 | 23.06.2010 | Renewal fee patent year 04 | 20.05.2011 | Renewal fee patent year 05 | 19.04.2012 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 19.07.2007 | AT | 08.08.2012 | BE | 08.08.2012 | CY | 08.08.2012 | CZ | 08.08.2012 | DK | 08.08.2012 | EE | 08.08.2012 | FI | 08.08.2012 | IT | 08.08.2012 | LT | 08.08.2012 | LV | 08.08.2012 | MC | 08.08.2012 | MT | 08.08.2012 | PL | 08.08.2012 | RO | 08.08.2012 | SE | 08.08.2012 | SI | 08.08.2012 | SK | 08.08.2012 | TR | 08.08.2012 | BG | 08.11.2012 | GR | 09.11.2012 | ES | 19.11.2012 | IS | 08.12.2012 | PT | 10.12.2012 | [2015/34] |
Former [2015/32] | AT | 08.08.2012 | |
BE | 08.08.2012 | ||
CY | 08.08.2012 | ||
CZ | 08.08.2012 | ||
DK | 08.08.2012 | ||
EE | 08.08.2012 | ||
FI | 08.08.2012 | ||
IT | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
MC | 08.08.2012 | ||
MT | 08.08.2012 | ||
PL | 08.08.2012 | ||
RO | 08.08.2012 | ||
SE | 08.08.2012 | ||
SI | 08.08.2012 | ||
SK | 08.08.2012 | ||
TR | 08.08.2012 | ||
BG | 08.11.2012 | ||
GR | 09.11.2012 | ||
ES | 19.11.2012 | ||
IS | 08.12.2012 | ||
PT | 10.12.2012 | ||
Former [2014/14] | AT | 08.08.2012 | |
BE | 08.08.2012 | ||
CY | 08.08.2012 | ||
CZ | 08.08.2012 | ||
DK | 08.08.2012 | ||
EE | 08.08.2012 | ||
FI | 08.08.2012 | ||
IT | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
MC | 08.08.2012 | ||
PL | 08.08.2012 | ||
RO | 08.08.2012 | ||
SE | 08.08.2012 | ||
SI | 08.08.2012 | ||
SK | 08.08.2012 | ||
BG | 08.11.2012 | ||
GR | 09.11.2012 | ||
ES | 19.11.2012 | ||
IS | 08.12.2012 | ||
PT | 10.12.2012 | ||
Former [2013/34] | AT | 08.08.2012 | |
BE | 08.08.2012 | ||
CY | 08.08.2012 | ||
CZ | 08.08.2012 | ||
DK | 08.08.2012 | ||
EE | 08.08.2012 | ||
FI | 08.08.2012 | ||
IT | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
PL | 08.08.2012 | ||
RO | 08.08.2012 | ||
SE | 08.08.2012 | ||
SI | 08.08.2012 | ||
SK | 08.08.2012 | ||
BG | 08.11.2012 | ||
GR | 09.11.2012 | ||
ES | 19.11.2012 | ||
IS | 08.12.2012 | ||
PT | 10.12.2012 | ||
Former [2013/23] | AT | 08.08.2012 | |
BE | 08.08.2012 | ||
CY | 08.08.2012 | ||
CZ | 08.08.2012 | ||
DK | 08.08.2012 | ||
EE | 08.08.2012 | ||
FI | 08.08.2012 | ||
IT | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
PL | 08.08.2012 | ||
RO | 08.08.2012 | ||
SE | 08.08.2012 | ||
SI | 08.08.2012 | ||
SK | 08.08.2012 | ||
GR | 09.11.2012 | ||
ES | 19.11.2012 | ||
IS | 08.12.2012 | ||
PT | 10.12.2012 | ||
Former [2013/22] | AT | 08.08.2012 | |
BE | 08.08.2012 | ||
CY | 08.08.2012 | ||
CZ | 08.08.2012 | ||
DK | 08.08.2012 | ||
EE | 08.08.2012 | ||
FI | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
PL | 08.08.2012 | ||
SE | 08.08.2012 | ||
SI | 08.08.2012 | ||
GR | 09.11.2012 | ||
ES | 19.11.2012 | ||
IS | 08.12.2012 | ||
PT | 10.12.2012 | ||
Former [2013/21] | AT | 08.08.2012 | |
BE | 08.08.2012 | ||
CY | 08.08.2012 | ||
DK | 08.08.2012 | ||
FI | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
PL | 08.08.2012 | ||
SE | 08.08.2012 | ||
SI | 08.08.2012 | ||
GR | 09.11.2012 | ||
IS | 08.12.2012 | ||
PT | 10.12.2012 | ||
Former [2013/13] | AT | 08.08.2012 | |
BE | 08.08.2012 | ||
CY | 08.08.2012 | ||
FI | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
PL | 08.08.2012 | ||
SE | 08.08.2012 | ||
SI | 08.08.2012 | ||
GR | 09.11.2012 | ||
IS | 08.12.2012 | ||
PT | 10.12.2012 | ||
Former [2013/12] | AT | 08.08.2012 | |
BE | 08.08.2012 | ||
CY | 08.08.2012 | ||
FI | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
PL | 08.08.2012 | ||
SE | 08.08.2012 | ||
SI | 08.08.2012 | ||
GR | 09.11.2012 | ||
IS | 08.12.2012 | ||
Former [2013/11] | AT | 08.08.2012 | |
CY | 08.08.2012 | ||
FI | 08.08.2012 | ||
LT | 08.08.2012 | ||
LV | 08.08.2012 | ||
PL | 08.08.2012 | ||
SI | 08.08.2012 | ||
GR | 09.11.2012 | ||
IS | 08.12.2012 | ||
Former [2013/10] | AT | 08.08.2012 | |
CY | 08.08.2012 | ||
FI | 08.08.2012 | ||
LT | 08.08.2012 | ||
IS | 08.12.2012 | ||
Former [2013/09] | AT | 08.08.2012 | |
FI | 08.08.2012 | ||
LT | 08.08.2012 | ||
Former [2013/08] | AT | 08.08.2012 | |
LT | 08.08.2012 | ||
Former [2013/07] | AT | 08.08.2012 | Documents cited: | Search | [X]WO03099862 (APPLIED NANOSYSTEMS BV [NL]; MOLL GERT NIKOLAAS [NL]; LEENHOUTS CORNEL) [X] 1-3,7-11 * accession number P00750: disulfide bridge 110-119; page 59 - page 60 *; | [A] - QI RUI-FENG ET AL, "Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application", ACTA BIOCHIMICA ET BIOPHYSICA SINICA, BLACKWELL PUBLISHING, INC., MALDEN, MA, US LNKD- DOI:10.1111/J.1745-7270.2005.00048.X, (20050501), vol. 37, no. 5, ISSN 1672-9145, pages 283 - 292, XP002524245 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.1111/j.1745-7270.2005.00048.x | International search | [A]US2003166003 (COCHRAN ANDREA G [US], et al) | [A] - MAGALHAES G.S. ET AL., "Natterins, a new class of proteins with kininogenase activity characterized from Thalassophryne nattereri fish venom", BIOCHIMIE, (200508), vol. 87, no. 8, pages 687 - 699, XP004996881 DOI: http://dx.doi.org/10.1016/j.biochi.2005.03.016 | by applicant | - RUI FENG ET AL., "Structural Features and Molecular Evolution of Bowman-Birk protease inhibitors and their potential application", ACTA BIOCHIMICA ET BIOPHYSICA SINICA, (2005), vol. 37, no. 5, doi:doi:10.1111/j.1745-7270.2005.00048.x, pages 283 - 292, XP002524245 DOI: http://dx.doi.org/10.1111/j.1745-7270.2005.00048.x |